| |
 |
Preface
 |
| |
|
pp.ii-ii (1) Author: Jean-François Riou |
| |
|
|
| |
|
Telomerase Inhibitors as Anticancer Therapy
|
| |
|
pp.567-575 (9) Authors: Masaharu Akiyama, Teru Hideshima, Nikhil C. Munshi, Kenneth C. Anderson |
| |
|
|
| |
|
Targeting Human Telomerase in Cancer Therapy
|
| |
|
pp.577-587 (11) Authors: Sylvain Huard, Chantal Autexier |
| |
|
|
| |
|
The ‘Other’ Telomerase Inhibitors: Non-G-Quadruplex Interactive Agent, Non-Antisense, Non-Reverse Transcriptase Telomerase Inhibitors
|
| |
|
pp.589-603 (15) Author: L. A. Beltz |
| |
|
|
| |
|
Targetin g Human Tel omerase by Antisens e Oligonucleotides and Ribozymes
|
| |
|
pp.605-612 (8) Authors: M. Folini, M. Pennati, N. Zaffaroni |
| |
|
|
| |
|
How to Inhibit Telomerase Activity for Cancer Therapy
|
| |
|
pp.613-626 (14) Authors: Satoru Kyo, Masaki Inoue |
| |
|
|
| |
|
Unusual DNA Conformations: Implications for Telomeres
|
| |
|
pp.627-644 (18) Authors: Martin Mills, Laurent Lacroix, Paola B. Arimondo, Jean-Louis Leroy, Jean-Christophe Francois, Horst Klump, Jean-Louis Mergny |
| |
|
|
